Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1 Study in Healthy Volunteers to Evaluate UDP glucuronosyl transferase (UGT) and Cytochrome (CYP) P450 - Mediated Drug-Drug Interactions Between GS-9688 and Probe Drugs

Trial Profile

A Phase 1 Study in Healthy Volunteers to Evaluate UDP glucuronosyl transferase (UGT) and Cytochrome (CYP) P450 - Mediated Drug-Drug Interactions Between GS-9688 and Probe Drugs

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Jul 2018

At a glance

  • Drugs GS 9688 (Primary) ; Ciprofloxacin; Probenecid; Rifampicin; Voriconazole
  • Indications Hepatitis B
  • Focus Pharmacokinetics
  • Sponsors Gilead Sciences
  • Most Recent Events

    • 09 Jul 2018 Status changed from not yet recruiting to completed.
    • 17 May 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top